Physician profile
Kathryn Mcbride Wright
NPI 1063978948
$2,195.60
in general payments reported to CMS, 2019-2025
25 companies · $369 in 2025
The $369 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $810 · 2022: $371 · 2023: $273 · 2024: $372 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,014.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $294.98 | 2021-2022 | |
| Stryker Corporation | $169.22 | 2024 | Surgicount |
| Azurity Pharmaceuticals, INC. | $151.07 | 2022-2024 | Triptodur, Triptodur |
| Takeda Pharmaceuticals U.S.A., INC. | $138.88 | 2022-2025 | Gattex, Eohilia |
| Eisai INC. | $132.91 | 2021 | |
| Coherus Oncology, INC. | $125.00 | 2021 | |
| Celgene Corporation | $124.87 | 2021 | |
| Janssen Pharmaceuticals, INC | $123.62 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $120.18 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $112.28 | 2021 | |
| Medline Industries LP | $102.67 | 2025 | |
| Sequel Med Tech, LLC | $89.93 | 2025 | Twiist |
| Pacira Pharmaceuticals Incorporated | $85.90 | 2023-2024 | Exparel |
| Medtronic, INC. | $79.98 | 2025 | Ligasure |
| Medical Device Business Services, INC. | $65.85 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $51.27 | 2023-2024 | Coolseal Generator |
| Alcresta Therapeutics, INC. | $39.43 | 2024 | Relizorb |
| Kyowa Kirin, INC. | $32.02 | 2025 | |
| Inspiremd LTD | $31.41 | 2025 | Cguard Prime Carotid Stent System |
| Molnlycke Health Care US, LLC | $29.30 | 2023 | Hibi Foam Pump, Biogel Indicator System, Hubs |
| Ultragenyx Pharmaceutical INC. | $27.09 | 2022 | |
| Endo Pharmaceuticals INC. | $18.87 | 2023 | Supprelin |
| Alexion Pharmaceuticals, INC. | $18.80 | 2025 | Strensiq |
| Adc Therapeutics America, INC. | $17.34 | 2022 | |
| Rigel Pharmaceuticals, INC. | $12.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.